Johnson Matthey to boost cash efficiency, cut spend in hydrogen technologies

(Reuters) – British autocatalyst maker Johnson Matthey (LON:JMAT) said on Monday it has implemented plans to significantly increase its cash efficiency and cut its capital expenditure in hydrogen technologies business following pressure from its top investor. Standard Investments, the largest shareholder in Johnson Matthey, last month had urged the group to initiate a strategic review…

Read More

Roche’s Elevidys shows sustained benefits in DMD study

Roche on Monday revealed positive results from the EMBARK trial, showing that its gene therapy Elevidys has sustained benefits for individuals with Duchenne muscular dystrophy (DMD) over a two-year period. The phase III study demonstrated significant improvements in motor functions, such as standing, walking, and running, compared to an untreated control group. The trial evaluated…

Read More

Julius Baer chairman Romeo Lacher to step down

(Reuters) – The chairman of Julius Baer (SIX:BAER), Romeo Lacher, is to step down, the Swiss bank said on Monday as it continued a shake-up of management that began a year ago after it suffered major losses from exposure to collapsed property group Signa. In a statement, Baer said that Lacher will not stand for…

Read More